Concepedia

Jiří Minařík

JM

41

Publications

3K

Citations

19

H-Index

2005

Active since

Affiliations

University Hospital Olomouc(Current)

Palacký University Olomouc

University Hospital Ostrava

Charles University

University Hospital Brno

Jiří Minařík is an author at University Hospital Olomouc specializing in hematology, oncology, and medicine.

ORCID

Top concepts

Publications per year

2005–2024

41

Publications

41

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

A. Keith Stewart, S. Vincent Rajkumar, Meletios Α. Dimopoulos et al. · New England Journal of Medicine · 2014 · 1.3K citations · Full text

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

Michel Attal, Paul G. Richardson, S. Vincent Rajkumar et al. · The Lancet · 2019 · 620 citations

, , +6

Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma

Hervé Avet‐Loiseau, Rafaël Fonseca, David S. Siegel et al. · Blood · 2016 · 120 citations · Full text

A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)

Roman Hájek, Tamás Masszi, Maria Teresa Petrucci et al. · Leukemia · 2016 · 118 citations · Full text

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

Annie Cowan, Federico Ferrari, Samuel S. Freeman et al. · The Lancet Haematology · 2023 · 72 citations · Full text

Rows per page

1–5 of 41